This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Trimetazidine
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict SKIP-PERMANENT HIGH
Real cardiac substrate-shifting drug with measurable angina relief in clinical trials. The athletic-performance signal is mostly inferential — there's no clean placebo-controlled human trial showing endurance benefit in healthy athletes, but mechanism is plausible and the WADA ban came after a string of cycling + skating positives. For a drug-tested combat athlete: SKIP-PERMANENT. For a non-tested user without angina: no clean evidence of benefit, real CNS side effects (Parkinsonism, restless legs, tremor — multiple EMA black-box-style restrictions added 2012), permanent movement-disorder cases documented in elderly post-marketing data. Risk/benefit is poor in healthy athletes.
▸ Verdict change log
- 2026-06-05 — Initial verdict SKIP-PERMANENT. WADA ban + movement-disorder risk + no clean healthy-athlete benefit data. (stub)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.